Business analyst Shaun Rein clashes at North Meridian with former Trump ambassador to Denmark Carla Sands on what Trump is achieving on China, Trump’s trade strategy, Taiwan, Iran, and whether Washington still has the leverage over Beijing that it thinks it does. Rein is the author of The Split: Finding the Opportunities in China’s Economy in the New World Order.Read More →

Drug deals dominated much of the international relations between biotech companies. But now, another change: the way China’s biotech companies structure their innovation shows a major shift, known widely as “NewCo,” says long-term China lawyer Mark Schaub on the website of his law firm, King&Wood.Read More →

Ian Johnson, author of China’s Underground Historians and their Battle for the Future and founder and director of China Unofficial Archives, discusses critical issues facing China at the Fairbank Center for Chinese Studies at Harvard University. “Reclaiming Historical Memory and the Struggle for China’s Future”.Read More →

China’s citizens have profoundly changed their view of the United States and their president, Trump, journalist Zhang Lijia writes at Democracy Asia.  He is called the “nation builder”, helping to improve the global standing of the country worldwide. “Many Chinese believe his erratic behaviour and foreign policy blunders weakened the United States and gave China greater diplomatic room to manoeuvre,” she writes. Read More →

In the past, China purchased licenses to sell medicines from Western companies. But today, China sells its own medicines to the West. The previously attractive market has changed profoundly, says China lawyer Mark Schaub on the website of his law firm King&Wood. “For many international companies if the question is “How do we sell into China?” then they may be increasingly playing yesterday’s game,” he writesRead More →